Fact CheckerSign in

NCT07129226Recruiting

Musculoskeletal Cancers Remote Monitoring and Care

Source: ClinicalTrials.gov · Last updated 6 Aug 2026

Brief summary (registry, in English)

This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
5 Aug 2025
Start date
12 Feb 2026
Primary completion date
30 Nov 2026
Lead sponsor
Case Comprehensive Cancer Center
Diseases
Sarcoma
NCT number
NCT07129226

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 12 Feb 2026 to the primary completion date, 30 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • tattoos located on the skin of the wrist or forearm where the watch will be placed or other skin conditions preventing adequate sensor function
  • amputation or other disease of the arm or skin that prevents wear of a smart-watch device

Age

  • under 18 years of age at the time of study enrolment

Other

  • inability to comprehend consent form and give informed consent
  • no access to a smartphone (iOS or Android) to interface with watch application
  • inability to tolerate watch for at least 12 hours per day on at least 80% of days in a four-week period

Who the study is looking for

  • primary sarcoma or metastatic bone disease of the lower extremities or pelvis.
  • undergoing evaluation for (or have recently undergone) non-surgical or surgical intervention.
  • recent history of home ambulation.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Case Comprehensive Cancer Center, Cleveland Clinic Foundation
Coordinator of this site? Confirm its status
ClevelandUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.